Trial Profile
Effects of Intensive Lipid Lowering and Omega-3 Fatty Acid on Composition of Coronary Atherosclerotic Plaque: Serial Virtual Histology Intravascular Ultrasound Analysis.
Status:
Recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Omega-3-fatty-acid (Primary)
- Indications Atherosclerosis
- Focus Therapeutic Use
- 14 Oct 2008 New trial record.